[1]
J. Peng, A.-K. Lalani, and A. Swaminath, “Cytoreductive stereotactic body radiotherapy (SBRT) and combination SBRT with immune checkpoint inhibitors in metastatic renal cell carcinoma”, CUAJ, vol. 15, no. 8, pp. 281–6, Jan. 2021.